Issue 220

22.10.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

 

SWITZERLAND IS SET TO LEGALISE MEDICAL AND ADULT-USE CANNABIS

Switzerland has announced its plans to legalise adult-use and medical cannabis, after a parliamentary commission ruled the drug should be taken off its banned substances list.

The Social Security and Health Commission of the Council of States (SGK-S) said cannabis should be regulated in Switzerland in order to control the cannabis market better, and to eliminate the black market for cannabis in the country.

READ MORE »

 


 

US SENATOR RELEASES TEXT FOR BILL TO LEGALISE ADULT-USE CANNABIS IN WASHINGTON D.C. 

READ MORE »

 

PAKISTANI MINISTER SAYS HE WILL PRESENT A CANNABIS CULTIVATION BILL BY DECEMBER 2021

READ MORE »

Europe

  • North Macedonia seeks foreign investment in its cannabis industry, to boost economy by €250 million.
  • The NHS’s medical cannabis programme remains inaccessible for most patients, with three prescriptions in three years.
  • An early study on cannabigerol indicates effectiveness on anxiety, chronic pain, depression and insomnia.
  • Poland’s hemp farming subsidies decrease 36% due to high THC levels in the predominantly grown hemp variety.
  • Demecan begins cannabis cultivation in Germany for medical purposes with deliveries expected for January 2022.
  • An increase in medical cannabis and CBD company listings on the stock exchange signals stability in the industry.
  • Adults in Luxembourg will soon be allowed to grow up to four cannabis plants after it legalises production and consumption.
  • The UK’s CIC discuss initiatives that include reviewing THC-limits in hemp foods, eligibility campaigns and more.
  • Cannabis telemedicine company Algea closes US$10 million financing round, to grow further in the digital health space.
  • Thought Leaders acquires Mellow for US$13.2 million, accessing the Asian and European markets.
  • Alternative plastics company to import hemp plastic into Europe from Colorado-based The Hemp Plastic Company.
  • Xebra enters the European market with the construction of its cannabis facility in the Netherlands.
  • Paris’s first Salon du CBD opens its doors, though the government plans a ban on CBD flowers for smoking.

Micellae

USA

CANADA

UPCOMING EVENT

JOIN GLOBAL LEADERS AND SHAPE THE FUTURE OF CANNABIS IN EUROPE AT CANNABIS EUROPA LONDON

Three weeks to go until Cannabis Europa London at the iconic Banking Hall – VIP Tickets have now completely SOLD OUT.

Secure your Advance Conference Ticket before Wednesday 27 October, when Final Release tickets go on sale and prices increase. Join us on 10-11 November alongside a host of the European cannabis industry’s key decision makers and investors. Let’s push things forward.

BUY TICKETS »

LATAM & CARIBBEAN

APAC

AFRICA & MIDDLE EAST

  • Gauteng’s government continues developing the region’s cannabis industry, calling for serious investment.
  • Israeli parliament to pass cannabis legislation giving 100,000 patients easier access to medical cannabis.
  • Israel’s medical cannabis patient registrations see a decrease for the first time in one and a half years.
  • The chairman of the National Tax Committee voices disdain of South Africa’s reluctance to legalise cannabis.
  • Uganda exports medical cannabis to Germany, its fourth ever international cannabis export since legalisation.

Read the stories that shape the cannabis industry